Home » Technologies » POC tests differentiate bacterial and viral RTIs

POC tests differentiate bacterial and viral RTIs

CRP and MxA point-of-care testing allows for quick and accurate differentiation between viral and bacterial respiratory tract infections (RTIs). The tests are based on a small fingertip blood sample and produce a quantitative result within minutes.

Advantages

Labmaster LUCIA™ tests are based on a small fingertip whole blood sample. The proprietary cathodic electrochemiluminescence technology guarantees accuracy of measurement. Its cost-effectiveness is achieved by replacing expensive optics with low-priced sophisticated electronics. A true quantitative result is ready within minutes. POC testing reduces the need for laboratory testing, expedites diagnostic decision-making and monitoring of treatment.

Specifications

Technology:

Infection prevention
Antimicrobial stewardship
Microbial diagnostics
Antimicrobial compound/strategy
Removal antibiotics/bacteria

Microorganisms:

Bacteria
Viruses
Fungi
Yeasts
Parasites

Application:

Human
Veterinary
AgriFood
Environmental
Other

Development stage:

Marketed product
Research
Development
Validation
Market entry

Organization:

Company
Academia
Institute
NGO
Government

Partnering:

License
Co-develop
Sell
Outsource
Joint Venture

Funding organisation:

OTHER / NA
CARB-X
FIND
GARDP
REPAIR

Infectious disease area:

RTI
UTI
STI
BSI
GII
SSTI
CNSI
IAI
SSI

Geographic origin:

Eurasia
North America
South America
Africa
Oceania

Partnering

Veterinary point-of-care diagnostics

Organisation

Labmaster Ltd, in Finland, develops innovative diagnostics tools for clinical and research use. The Labmaster LUCIA™ Analyzer is a point of-care immunoassay platform based on patented cathodic electrochemiluminescence (LM-CECL) technology. It enables fast, accurate and affordable human and veterinary diagnostics of biomarkers in blood samples.

Other